[Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?]

Rev Med Interne. 2009 Dec;30(12):1001-3. doi: 10.1016/j.revmed.2009.08.003. Epub 2009 Oct 14.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control
  • Coronary Artery Disease / etiology
  • Coronary Artery Disease / prevention & control*
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Meta-Analysis as Topic
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Primary Prevention / methods*
  • Risk Factors

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin